NPM1 and acute myeloid leukemia: In this regard, in MPN1-mutated AML, NPM1-mA was shown to recue fat mass and obesity-associated (FTO) protein from proteasomal degradation to reduce the global m6A abundance, leading to the activation of the PDGFRB/ERK signalling axis to autonomously drive leukaemic blast survival [139].